Noninvasive Evaluation of CD20 Expression Using Cu-64-Labeled F(ab ')(2) Fragments of Obinutuzumab in Lymphoma

Kang, L; Li, CC; Rosenkrans, ZT; Engle, JW; Wang, RF; Jiang, DW; Xu, XJ; Cai, WB

Cai, WB (corresponding author), Univ Wisconsin, 1111 Highland Ave,Room 7137, Madison, WI 53705 USA.; Xu, XJ (corresponding author), 27 Taiping Rd, Beijing 100850, Peoples R China.; Jiang, DW (corresponding author), 1277 Jiefang Ave, Wuhan 430022, Hubei, Peoples R China.; Kang, L (corresponding author), 8 Xishiku St, Beijing 100034, Peoples R China.

JOURNAL OF NUCLEAR MEDICINE, 2021; 62 (3): 372

Abstract

CD20-overexpressed non-Hodgkin lymphoma typically indicates progressive malignancy. Obinutuzumab is a next-generation Food and Drug Administration-app......

Full Text Link